Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes

The role of phospholipase A2 (PLA2) enzymes in the degradation of internalized dipalmitoylphospharidylcoline (DPPC) by rat granular pneumocytes was evaluated with cells in 24 h primary culture on microporous membranes. In cell sonicates and rat lung homogenates, the transition state analogue MJ33 in...

Full description

Bibliographic Details
Main Authors: A B Fisher, C Dodia
Format: Article
Language:English
Published: Elsevier 1996-05-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520420152
_version_ 1818385200412884992
author A B Fisher
C Dodia
author_facet A B Fisher
C Dodia
author_sort A B Fisher
collection DOAJ
description The role of phospholipase A2 (PLA2) enzymes in the degradation of internalized dipalmitoylphospharidylcoline (DPPC) by rat granular pneumocytes was evaluated with cells in 24 h primary culture on microporous membranes. In cell sonicates and rat lung homogenates, the transition state analogue MJ33 inhibited acidic (pH 4), Ca(2+)-independent PLA2 (aiPLA2) while p-bromophenacylbromide (pBPB) inhibited alkaline (pH 8.5), Ca(2+)-dependent PLA2 and phospholipase C activities. With intact cells, degradation of [3H]methylcholine-labeled DPPC during 2 h incubation was inhibited 48% by MJ33, 20% by pBPB, and 69%by the combination. The inhibitors (20 microM pBPB, 3 mol% MJ33) had no effect on cellular dye exclusion, adherence to membranes, or uptake of DPPC. Arachidonyl trifuoromethylketone, a cytoplasmic PLA2 inhibitor, had no effect on cellular degradation of DPPC. Degradation was depressed approximately 20% by the addition of NH4Cl or methylamine to the medium, suggesting a role for an acidic intracellular compartment in DPPC metabolism. Subcellular fractions prepared by differential centrifugation of rat lung homogenates showed highest specific activity of aiPLA2 in the lamellar body and lysosomal fractions, lower activity in cytosol, and essentially no activity in mitochondria, microsomes, or plasma membranes. The results of this study indicate that aiPLA2 has the major role in the degradation of internalized DPPC by granular pneumocytes and they are compatible with participation of lysosomes/lamellar bodies in DPPC metabolism.
first_indexed 2024-12-14T03:34:22Z
format Article
id doaj.art-c9723c9aaa824b18bbb613001bde0e89
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-14T03:34:22Z
publishDate 1996-05-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-c9723c9aaa824b18bbb613001bde0e892022-12-21T23:18:39ZengElsevierJournal of Lipid Research0022-22751996-05-0137510571064Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytesA B Fisher0C Dodia1Institute for Environmental Medicine, University of Pennsylvania Medical Center, Philadelphia 19104, USA.Institute for Environmental Medicine, University of Pennsylvania Medical Center, Philadelphia 19104, USA.The role of phospholipase A2 (PLA2) enzymes in the degradation of internalized dipalmitoylphospharidylcoline (DPPC) by rat granular pneumocytes was evaluated with cells in 24 h primary culture on microporous membranes. In cell sonicates and rat lung homogenates, the transition state analogue MJ33 inhibited acidic (pH 4), Ca(2+)-independent PLA2 (aiPLA2) while p-bromophenacylbromide (pBPB) inhibited alkaline (pH 8.5), Ca(2+)-dependent PLA2 and phospholipase C activities. With intact cells, degradation of [3H]methylcholine-labeled DPPC during 2 h incubation was inhibited 48% by MJ33, 20% by pBPB, and 69%by the combination. The inhibitors (20 microM pBPB, 3 mol% MJ33) had no effect on cellular dye exclusion, adherence to membranes, or uptake of DPPC. Arachidonyl trifuoromethylketone, a cytoplasmic PLA2 inhibitor, had no effect on cellular degradation of DPPC. Degradation was depressed approximately 20% by the addition of NH4Cl or methylamine to the medium, suggesting a role for an acidic intracellular compartment in DPPC metabolism. Subcellular fractions prepared by differential centrifugation of rat lung homogenates showed highest specific activity of aiPLA2 in the lamellar body and lysosomal fractions, lower activity in cytosol, and essentially no activity in mitochondria, microsomes, or plasma membranes. The results of this study indicate that aiPLA2 has the major role in the degradation of internalized DPPC by granular pneumocytes and they are compatible with participation of lysosomes/lamellar bodies in DPPC metabolism.http://www.sciencedirect.com/science/article/pii/S0022227520420152
spellingShingle A B Fisher
C Dodia
Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
Journal of Lipid Research
title Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
title_full Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
title_fullStr Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
title_full_unstemmed Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
title_short Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
title_sort role of phospholipase a2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes
url http://www.sciencedirect.com/science/article/pii/S0022227520420152
work_keys_str_mv AT abfisher roleofphospholipasea2enzymesindegradationofdipalmitoylphosphatidylcholinebygranularpneumocytes
AT cdodia roleofphospholipasea2enzymesindegradationofdipalmitoylphosphatidylcholinebygranularpneumocytes